Gregory Renza Analyst PerformanceAnalyst at Royal Bank Of CanadaGregory Renza is a stock analyst at Royal Bank Of Canada in the medical sector, covering 29 publicly traded companies. Over the past year, Gregory Renza has issued 49 stock ratings, including buy and hold recommendations. While full access to Gregory Renza's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Gregory Renza's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings73 Last 6 YearsBuy Recommendations83.82% 57 Buy RatingsCompanies Covered29 Unique Companies Ratings Distribution68RatingsDistribution of strong buy, buy, hold, and sell ratings by Gregory Renza.RatingPercentageCount Strong Buy0.0%0 ratings Buy83.8%57 ratings Hold16.2%11 ratings Sell0.0%0 ratingsOut of 68 total stock ratings issued by Gregory Renza at Royal Bank Of Canada, the majority (83.8%) have been Buy recommendations, followed by 16.2% Hold.Best & Worst CallsBest Call0000.0%CGONApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AVTXMar 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ89.7% of companies on NASDAQ26 companiesNYSE6.9% of companies on NYSE2 companiesNYSEAMERICAN3.4% of companies on NYSEAMERICAN1 companyGregory Renza, an analyst at Royal Bank Of Canada, currently covers 29 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical29 companies100.0%Gregory Renza of Royal Bank Of Canada specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE23 companies79.3%MED - DRUGS4 companies13.8%SURGICAL & MEDICAL INSTRUMENTS1 company3.4%PHARMACEUTICAL PREPARATIONS1 company3.4% Gregory Renza's Ratings History at Royal Bank Of Canada Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRVMDRevolution Medicines5/18/2026Initiated Coverage$145.66$179.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals5/18/2026Lower Price Target$624.63$778.00Buy$0.0000.00% ROICGONCG Oncology5/14/2026Reiterated Rating$69.15$82.00Buy$0.0000.00% ROICGONCG Oncology5/11/2026Reiterated Rating$70.56$77.00Buy$0.0000.00% ROIGILDGilead Sciences5/8/2026Reiterated Rating$131.22$157.00Buy$0.0000.00% ROIONCBeOne Medicines5/7/2026Reiterated Rating$311.80$413.00Buy$0.0000.00% ROIAMGNAmgen5/1/2026Boost Price Target$328.59$327.00Hold$0.0000.00% ROIAGIOAgios Pharmaceuticals4/30/2026Lower Price Target$28.05$36.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals4/30/2026Lower Price Target$705.87$796.00Buy$0.0000.00% ROIVRDNViridian Therapeutics4/21/2026Lower Price Target$14.68$33.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. REGNRegeneron Pharmaceuticals3/31/2026Lower Price Target$766.43$801.00Buy$0.0000.00% ROIONCBeOne Medicines2/27/2026Boost Price Target$318.67$412.00Buy$0.0000.00% ROIFULCFulcrum Therapeutics2/24/2026Set Price Target$8.96$17.00$0.0000.00% ROIGILDGilead Sciences2/11/2026Boost Price Target$155.91$152.00Buy$0.0000.00% ROICGONCG Oncology2/10/2026Boost Price Target$51.08$75.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals2/2/2026Lower Price Target$757.62$818.00Buy$0.0000.00% ROINUVBNuvation Bio1/27/2026Set Price Target$5.61$13.00$0.0000.00% ROIGILDGilead Sciences1/27/2026Boost Price Target$140.75$145.00Buy$0.0000.00% ROICGONCG Oncology1/9/2026Boost Price Target$54.23$66.00Buy$0.0000.00% ROIAMGNAmgen1/8/2026Boost Price Target$335.74$319.00Hold$0.0000.00% ROIVRDNViridian Therapeutics1/8/2026Lower Price Target$30.45$40.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals1/8/2026Boost Price Target$814.10$820.00Buy$0.0000.00% ROIIDYAIDEAYA Biosciences1/6/2026Boost Price Target$34.94$60.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals12/24/2025Boost Price Target$29.05$38.00Buy$0.0000.00% ROIFULCFulcrum Therapeutics12/11/2025Boost Price Target$13.00$18.00Buy$0.0000.00% ROIADCTADC Therapeutics12/3/2025Reiterated Rating$3.51$5.00Outperform$0.0000.00% ROICGONCG Oncology11/24/2025Set Price Target$42.44$62.00$0.0000.00% ROIBCYCBicycle Therapeutics11/24/2025Initiated Coverage$6.32$10.00Hold$0.0000.00% ROIAAPGAscentage Pharma Group International11/24/2025Set Price Target$30.64$51.00$0.0000.00% ROIABVXAbivax11/24/2025Set Price Target$119.12$140.00$0.0000.00% ROIXNCRXencor11/24/2025Initiated Coverage$15.87$29.00Buy$0.0000.00% ROIBCYCBicycle Therapeutics11/24/2025Initiated Coverage$6.32$19.00Hold$0.0000.00% ROINRIXNurix Therapeutics11/24/2025Initiated Coverage$17.37$30.00Buy$0.0000.00% ROICATXPerspective Therapeutics11/24/2025Initiated Coverage$2.17$12.00Buy$0.0000.00% ROIAMGNAmgen11/24/2025Initiated Coverage$337.84$318.00Hold$0.0000.00% ROIXNCRXencor11/24/2025Initiated Coverage$15.87$29.00Buy$0.0000.00% ROIVRDNViridian Therapeutics11/24/2025Initiated Coverage$30.34$41.00Buy$0.0000.00% ROIONCBeOne Medicines11/24/2025Initiated Coverage$347.72$400.00Buy$0.0000.00% ROINUVLNuvalent11/24/2025Initiated Coverage$105.88$140.00Buy$0.0000.00% ROINUVBNuvation Bio11/24/2025Initiated Coverage$7.01$11.00Buy$0.0000.00% ROIThe Iran War Just Broke the Gold Market (Ad)The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged… Defense stocks exploded…And gold ripped past $5,000.You can see the evidence — and the ticker symbol — here >>>MNKDMannKind11/24/2025Initiated Coverage$5.03$9.00Buy$0.0000.00% ROIIDYAIDEAYA Biosciences11/24/2025Initiated Coverage$33.99$59.00Buy$0.0000.00% ROIFULCFulcrum Therapeutics11/24/2025Initiated Coverage$11.29$14.00Buy$0.0000.00% ROICGONCG Oncology11/24/2025Initiated Coverage$42.44$62.00Buy$0.0000.00% ROIAGIOAgios Pharmaceuticals11/24/2025Initiated Coverage$25.24$32.00Buy$0.0000.00% ROIABVXAbivax11/24/2025Initiated Coverage$119.12$140.00Buy$0.0000.00% ROIAAPGAscentage Pharma Group International11/24/2025Initiated Coverage$30.64$51.00Buy$0.0000.00% ROINRIXNurix Therapeutics10/22/2025Reiterated Rating$10.63$29.00Outperform$0.0000.00% ROICRMDCorMedix10/21/2025Reiterated Rating$12.16$22.00Outperform$0.0000.00% ROIACADACADIA Pharmaceuticals5/19/2025Reiterated Rating$22.01$26.00Outperform$00.0000.00% ROIADCTADC Therapeutics5/15/2025Reiterated Rating$1.81$8.00Outperform$0.0000.00% ROIINOInovio Pharmaceuticals5/14/2025Reiterated Rating$1.86$5.00Sector Perform$0.0000.00% ROIEXELExelixis5/14/2025Reiterated Rating$43.58$40.00Outperform$00.0000.00% ROIJAZZJazz Pharmaceuticals5/7/2025Lower Price Target$102.22$172.00Outperform$000.0000.00% ROIBCYCBicycle Therapeutics5/2/2025Lower Price Target$9.43$32.00Outperform$0.0000.00% ROIAMGNAmgen5/2/2025Lower Price Target$279.88$320.00Outperform$000.0000.00% ROICGONCG Oncology4/29/2025Boost Price Target$27.91$68.00Outperform$00.0000.00% ROISPRBSpruce Biosciences4/16/2025Lower Price Target$9.62$37.50Sector Perform$00.0000.00% ROICATXPerspective Therapeutics3/27/2025Lower Price Target$2.36$15.00Outperform$0.0000.00% ROICRMDCorMedix3/26/2025Reiterated Rating$7.15$12.00Outperform$0.0000.00% ROIVSTMVerastem3/21/2025Lower Price Target$6.69$14.00Outperform$0.0000.00% ROIINOInovio Pharmaceuticals3/19/2025Lower Price Target$2.03$5.00Sector Perform$0.0000.00% ROIEXELExelixis3/13/2025Boost Price Target$36.92$40.00Outperform$00.0000.00% ROIJAZZJazz Pharmaceuticals2/26/2025Lower Price Target$146.23$178.00Outperform$000.0000.00% ROINRIXNurix Therapeutics1/29/2025Boost Price Target$20.07$27.00Outperform$00.0000.00% ROIAMGNAmgen1/24/2025Reiterated Rating$275.63$324.00Outperform$000.0000.00% ROIIDYAIDEAYA Biosciences1/15/2025Reiterated Rating$23.64$61.00Outperform$00.0000.00% ROICATXPerspective Therapeutics1/14/2025Reiterated Rating$3.22$16.00Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
